טוען...

Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study

BACKGROUND AND AIMS: The widespread use of anti‐tumour necrosis factor α antibody (Infliximab) in Crohn's disease (CD) raises concerns about a possible cancer risk in the long term. In a matched pair study, we assessed whether Infliximab is associated with an increased risk of neoplasia. METHOD...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
Main Authors:	Biancone, L, Orlando, A, Kohn, A, Colombo, E, Sostegni, R, Angelucci, E, Rizzello, F, Castiglione, F, Benazzato, L, Papi, C, Meucci, G, Riegler, G, Petruzziello, C, Mocciaro, F, Geremia, A, Calabrese, E, Cottone, M, Pallone, F
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMJ Group 2006
נושאים:	Inflammatory Bowel Disease
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC1856527/ https://ncbi.nlm.nih.gov/pubmed/16120759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.075937
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study

פריטים דומים